Reports

Industry Research Reports

Global Brain Pill Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Brain Pill Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-09-06

Pages: 97 Pages

Report ld: 4977447

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Brain Pill market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Brain Pill market competitiveness, regional economic performance, and supply chain configurations.

The North America Brain Pill market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key manufacturers of Brain Pill include Leading Edge Health Company, BL Bio Lab, Natural Factors Nutritional Products Ltd, Onnit Labs, Inc., Intelligent Labs, HVMN Inc., Neuriva, Purelife Bioscience Co., Ltd, Accelerated Intelligence Inc., NOW Foods, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Brain Pill market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

By Company

  • Leading Edge Health Company
  • BL Bio Lab
  • Natural Factors Nutritional Products Ltd
  • Onnit Labs, Inc.
  • Intelligent Labs
  • HVMN Inc.
  • Neuriva
  • Purelife Bioscience Co., Ltd
  • Accelerated Intelligence Inc.
  • NOW Foods
  • Alternascript
  • Teva Pharmaceutical Industries Ltd.
  • Peak Nootropics
  • KeyView Labs

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Fish Oil
  • Resveratrol
  • Creatine
  • Others

Segment by Application

  • Online Sales
  • Offline Sales

biaoTi Chapter Outline

marn_i1

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

marn_i1

Chapter 2: Quantitative analysis of Brain Pill market size and growth potential at global, regional, and country levels.

marn_i1

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

marn_i1

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Resveratrol in China).

marn_i1

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Offline Sales in India).

marn_i1

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

marn_i1

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

marn_i1

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 9: Actionable conclusions and strategic recommendations.

marn_i1

Why This Report?

marn_i1

This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:

marn_i1

- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).

marn_i1

- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Fish Oil dominance in Europe vs. Resveratrol demand in MEA).

marn_i1

- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

biaoTi QYResearch's Strengths

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

Table of Contents

muLu

1 Market Overview

1.1 Brain Pill Product Scope

1.2 Brain Pill by Type

1.2.1 Global Brain Pill Sales by Type (2020 & 2024 & 2031)

1.2.2 Fish Oil

1.2.3 Resveratrol

1.2.4 Creatine

1.2.5 Others

1.3 Brain Pill by Application

1.3.1 Global Brain Pill Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Online Sales

1.3.3 Offline Sales

1.4 Global Brain Pill Market Estimates and Forecasts (2020-2031)

1.4.1 Global Brain Pill Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Brain Pill Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Brain Pill Price Trends (2020-2031)

1.5 Assumptions and Limitations

muLu

2 Market Size and Prospective by Region

2.1 Global Brain Pill Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Brain Pill Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Brain Pill Sales Market Share by Region (2020-2025)

2.2.2 Global Brain Pill Revenue Market Share by Region (2020-2025)

2.3 Global Brain Pill Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Brain Pill Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Brain Pill Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Brain Pill Market Size and Prospective (2020-2031)

2.4.2 Europe Brain Pill Market Size and Prospective (2020-2031)

2.4.3 China Brain Pill Market Size and Prospective (2020-2031)

2.4.4 Japan Brain Pill Market Size and Prospective (2020-2031)

muLu

3 Global Market Size by Type

3.1 Global Brain Pill Historic Market Review by Type (2020-2025)

3.1.1 Global Brain Pill Sales by Type (2020-2025)

3.1.2 Global Brain Pill Revenue by Type (2020-2025)

3.1.3 Global Brain Pill Price by Type (2020-2025)

3.2 Global Brain Pill Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Brain Pill Sales Forecast by Type (2026-2031)

3.2.2 Global Brain Pill Revenue Forecast by Type (2026-2031)

3.2.3 Global Brain Pill Price Forecast by Type (2026-2031)

3.3 Different Types Brain Pill Representative Players

muLu

4 Global Market Size by Application

4.1 Global Brain Pill Historic Market Review by Application (2020-2025)

4.1.1 Global Brain Pill Sales by Application (2020-2025)

4.1.2 Global Brain Pill Revenue by Application (2020-2025)

4.1.3 Global Brain Pill Price by Application (2020-2025)

4.2 Global Brain Pill Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Brain Pill Sales Forecast by Application (2026-2031)

4.2.2 Global Brain Pill Revenue Forecast by Application (2026-2031)

4.2.3 Global Brain Pill Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Brain Pill Application

muLu

5 Competition Landscape by Players

5.1 Global Brain Pill Sales by Players (2020-2025)

5.2 Global Top Brain Pill Players by Revenue (2020-2025)

5.3 Global Brain Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Pill as of 2024)

5.4 Global Brain Pill Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Brain Pill, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Brain Pill, Product Type & Application

5.7 Global Key Manufacturers of Brain Pill, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Brain Pill Sales by Company

6.1.1.1 North America Brain Pill Sales by Company (2020-2025)

6.1.1.2 North America Brain Pill Revenue by Company (2020-2025)

6.1.2 North America Brain Pill Sales Breakdown by Type (2020-2025)

6.1.3 North America Brain Pill Sales Breakdown by Application (2020-2025)

6.1.4 North America Brain Pill Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Brain Pill Sales by Company

6.2.1.1 Europe Brain Pill Sales by Company (2020-2025)

6.2.1.2 Europe Brain Pill Revenue by Company (2020-2025)

6.2.2 Europe Brain Pill Sales Breakdown by Type (2020-2025)

6.2.3 Europe Brain Pill Sales Breakdown by Application (2020-2025)

6.2.4 Europe Brain Pill Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Brain Pill Sales by Company

6.3.1.1 China Brain Pill Sales by Company (2020-2025)

6.3.1.2 China Brain Pill Revenue by Company (2020-2025)

6.3.2 China Brain Pill Sales Breakdown by Type (2020-2025)

6.3.3 China Brain Pill Sales Breakdown by Application (2020-2025)

6.3.4 China Brain Pill Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Brain Pill Sales by Company

6.4.1.1 Japan Brain Pill Sales by Company (2020-2025)

6.4.1.2 Japan Brain Pill Revenue by Company (2020-2025)

6.4.2 Japan Brain Pill Sales Breakdown by Type (2020-2025)

6.4.3 Japan Brain Pill Sales Breakdown by Application (2020-2025)

6.4.4 Japan Brain Pill Major Customer

6.4.5 Japan Market Trend and Opportunities

muLu

7 Company Profiles and Key Figures

7.1 Leading Edge Health Company

7.1.1 Leading Edge Health Company Company Information

7.1.2 Leading Edge Health Company Business Overview

7.1.3 Leading Edge Health Company Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Leading Edge Health Company Brain Pill Products Offered

7.1.5 Leading Edge Health Company Recent Development

7.2 BL Bio Lab

7.2.1 BL Bio Lab Company Information

7.2.2 BL Bio Lab Business Overview

7.2.3 BL Bio Lab Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.2.4 BL Bio Lab Brain Pill Products Offered

7.2.5 BL Bio Lab Recent Development

7.3 Natural Factors Nutritional Products Ltd

7.3.1 Natural Factors Nutritional Products Ltd Company Information

7.3.2 Natural Factors Nutritional Products Ltd Business Overview

7.3.3 Natural Factors Nutritional Products Ltd Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Natural Factors Nutritional Products Ltd Brain Pill Products Offered

7.3.5 Natural Factors Nutritional Products Ltd Recent Development

7.4 Onnit Labs, Inc.

7.4.1 Onnit Labs, Inc. Company Information

7.4.2 Onnit Labs, Inc. Business Overview

7.4.3 Onnit Labs, Inc. Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Onnit Labs, Inc. Brain Pill Products Offered

7.4.5 Onnit Labs, Inc. Recent Development

7.5 Intelligent Labs

7.5.1 Intelligent Labs Company Information

7.5.2 Intelligent Labs Business Overview

7.5.3 Intelligent Labs Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Intelligent Labs Brain Pill Products Offered

7.5.5 Intelligent Labs Recent Development

7.6 HVMN Inc.

7.6.1 HVMN Inc. Company Information

7.6.2 HVMN Inc. Business Overview

7.6.3 HVMN Inc. Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.6.4 HVMN Inc. Brain Pill Products Offered

7.6.5 HVMN Inc. Recent Development

7.7 Neuriva

7.7.1 Neuriva Company Information

7.7.2 Neuriva Business Overview

7.7.3 Neuriva Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Neuriva Brain Pill Products Offered

7.7.5 Neuriva Recent Development

7.8 Purelife Bioscience Co., Ltd

7.8.1 Purelife Bioscience Co., Ltd Company Information

7.8.2 Purelife Bioscience Co., Ltd Business Overview

7.8.3 Purelife Bioscience Co., Ltd Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Purelife Bioscience Co., Ltd Brain Pill Products Offered

7.8.5 Purelife Bioscience Co., Ltd Recent Development

7.9 Accelerated Intelligence Inc.

7.9.1 Accelerated Intelligence Inc. Company Information

7.9.2 Accelerated Intelligence Inc. Business Overview

7.9.3 Accelerated Intelligence Inc. Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Accelerated Intelligence Inc. Brain Pill Products Offered

7.9.5 Accelerated Intelligence Inc. Recent Development

7.10 NOW Foods

7.10.1 NOW Foods Company Information

7.10.2 NOW Foods Business Overview

7.10.3 NOW Foods Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.10.4 NOW Foods Brain Pill Products Offered

7.10.5 NOW Foods Recent Development

7.11 Alternascript

7.11.1 Alternascript Company Information

7.11.2 Alternascript Business Overview

7.11.3 Alternascript Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Alternascript Brain Pill Products Offered

7.11.5 Alternascript Recent Development

7.12 Teva Pharmaceutical Industries Ltd.

7.12.1 Teva Pharmaceutical Industries Ltd. Company Information

7.12.2 Teva Pharmaceutical Industries Ltd. Business Overview

7.12.3 Teva Pharmaceutical Industries Ltd. Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Teva Pharmaceutical Industries Ltd. Brain Pill Products Offered

7.12.5 Teva Pharmaceutical Industries Ltd. Recent Development

7.13 Peak Nootropics

7.13.1 Peak Nootropics Company Information

7.13.2 Peak Nootropics Business Overview

7.13.3 Peak Nootropics Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Peak Nootropics Brain Pill Products Offered

7.13.5 Peak Nootropics Recent Development

7.14 KeyView Labs

7.14.1 KeyView Labs Company Information

7.14.2 KeyView Labs Business Overview

7.14.3 KeyView Labs Brain Pill Sales, Revenue and Gross Margin (2020-2025)

7.14.4 KeyView Labs Brain Pill Products Offered

7.14.5 KeyView Labs Recent Development

muLu

8 Brain Pill Manufacturing Cost Analysis

8.1 Brain Pill Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Brain Pill

8.4 Brain Pill Industrial Chain Analysis

muLu

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Brain Pill Distributors List

9.3 Brain Pill Customers

muLu

10 Brain Pill Market Dynamics

10.1 Brain Pill Industry Trends

10.2 Brain Pill Market Drivers

10.3 Brain Pill Market Challenges

10.4 Brain Pill Market Restraints

muLu

11 Research Findings and Conclusion

muLu

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

den_biaoTiZhungShi

Table of Figures

muLu

List of Tables

Table 1. Global Brain Pill Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Brain Pill Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Brain Pill Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Brain Pill Sales (K Units) by Region (2020-2025)
Table 5. Global Brain Pill Sales Market Share by Region (2020-2025)
Table 6. Global Brain Pill Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Brain Pill Revenue Share by Region (2020-2025)
Table 8. Global Brain Pill Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Brain Pill Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Brain Pill Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Brain Pill Revenue Share Forecast by Region (2026-2031)
Table 12. Global Brain Pill Sales by Type (K Units) & (2020-2025)
Table 13. Global Brain Pill Sales Share by Type (2020-2025)
Table 14. Global Brain Pill Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Brain Pill Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Brain Pill Sales by Type (K Units) & (2026-2031)
Table 17. Global Brain Pill Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Brain Pill Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Brain Pill Sales by Application (K Units) & (2020-2025)
Table 21. Global Brain Pill Sales Share by Application (2020-2025)
Table 22. Global Brain Pill Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Brain Pill Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Brain Pill Sales by Application (K Units) & (2026-2031)
Table 25. Global Brain Pill Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Brain Pill Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Brain Pill Application
Table 28. Global Brain Pill Sales by Company (K Units) & (2020-2025)
Table 29. Global Brain Pill Sales Share by Company (2020-2025)
Table 30. Global Brain Pill Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Brain Pill Revenue Share by Company (2020-2025)
Table 32. Global Brain Pill by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Pill as of 2024)
Table 33. Global Market Brain Pill Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Brain Pill, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Brain Pill, Product Type & Application
Table 36. Global Key Manufacturers of Brain Pill, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Brain Pill Sales by Company (2020-2025) & (K Units)
Table 39. North America Brain Pill Sales Market Share by Company (2020-2025)
Table 40. North America Brain Pill Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Brain Pill Revenue Market Share by Company (2020-2025)
Table 42. North America Brain Pill Sales by Type (2020-2025) & (K Units)
Table 43. North America Brain Pill Sales Market Share by Type (2020-2025)
Table 44. North America Brain Pill Sales by Application (2020-2025) & (K Units)
Table 45. North America Brain Pill Sales Market Share by Application (2020-2025)
Table 46. Europe Brain Pill Sales by Company (2020-2025) & (K Units)
Table 47. Europe Brain Pill Sales Market Share by Company (2020-2025)
Table 48. Europe Brain Pill Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Brain Pill Revenue Market Share by Company (2020-2025)
Table 50. Europe Brain Pill Sales by Type (2020-2025) & (K Units)
Table 51. Europe Brain Pill Sales Market Share by Type (2020-2025)
Table 52. Europe Brain Pill Sales by Application (2020-2025) & (K Units)
Table 53. Europe Brain Pill Sales Market Share by Application (2020-2025)
Table 54. China Brain Pill Sales by Company (2020-2025) & (K Units)
Table 55. China Brain Pill Sales Market Share by Company (2020-2025)
Table 56. China Brain Pill Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Brain Pill Revenue Market Share by Company (2020-2025)
Table 58. China Brain Pill Sales by Type (2020-2025) & (K Units)
Table 59. China Brain Pill Sales Market Share by Type (2020-2025)
Table 60. China Brain Pill Sales by Application (2020-2025) & (K Units)
Table 61. China Brain Pill Sales Market Share by Application (2020-2025)
Table 62. Japan Brain Pill Sales by Company (2020-2025) & (K Units)
Table 63. Japan Brain Pill Sales Market Share by Company (2020-2025)
Table 64. Japan Brain Pill Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Brain Pill Revenue Market Share by Company (2020-2025)
Table 66. Japan Brain Pill Sales by Type (2020-2025) & (K Units)
Table 67. Japan Brain Pill Sales Market Share by Type (2020-2025)
Table 68. Japan Brain Pill Sales by Application (2020-2025) & (K Units)
Table 69. Japan Brain Pill Sales Market Share by Application (2020-2025)
Table 70. Leading Edge Health Company Company Information
Table 71. Leading Edge Health Company Description and Business Overview
Table 72. Leading Edge Health Company Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Leading Edge Health Company Brain Pill Product
Table 74. Leading Edge Health Company Recent Development
Table 75. BL Bio Lab Company Information
Table 76. BL Bio Lab Description and Business Overview
Table 77. BL Bio Lab Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. BL Bio Lab Brain Pill Product
Table 79. BL Bio Lab Recent Development
Table 80. Natural Factors Nutritional Products Ltd Company Information
Table 81. Natural Factors Nutritional Products Ltd Description and Business Overview
Table 82. Natural Factors Nutritional Products Ltd Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Natural Factors Nutritional Products Ltd Brain Pill Product
Table 84. Natural Factors Nutritional Products Ltd Recent Development
Table 85. Onnit Labs, Inc. Company Information
Table 86. Onnit Labs, Inc. Description and Business Overview
Table 87. Onnit Labs, Inc. Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Onnit Labs, Inc. Brain Pill Product
Table 89. Onnit Labs, Inc. Recent Development
Table 90. Intelligent Labs Company Information
Table 91. Intelligent Labs Description and Business Overview
Table 92. Intelligent Labs Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Intelligent Labs Brain Pill Product
Table 94. Intelligent Labs Recent Development
Table 95. HVMN Inc. Company Information
Table 96. HVMN Inc. Description and Business Overview
Table 97. HVMN Inc. Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. HVMN Inc. Brain Pill Product
Table 99. HVMN Inc. Recent Development
Table 100. Neuriva Company Information
Table 101. Neuriva Description and Business Overview
Table 102. Neuriva Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Neuriva Brain Pill Product
Table 104. Neuriva Recent Development
Table 105. Purelife Bioscience Co., Ltd Company Information
Table 106. Purelife Bioscience Co., Ltd Description and Business Overview
Table 107. Purelife Bioscience Co., Ltd Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Purelife Bioscience Co., Ltd Brain Pill Product
Table 109. Purelife Bioscience Co., Ltd Recent Development
Table 110. Accelerated Intelligence Inc. Company Information
Table 111. Accelerated Intelligence Inc. Description and Business Overview
Table 112. Accelerated Intelligence Inc. Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Accelerated Intelligence Inc. Brain Pill Product
Table 114. Accelerated Intelligence Inc. Recent Development
Table 115. NOW Foods Company Information
Table 116. NOW Foods Description and Business Overview
Table 117. NOW Foods Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. NOW Foods Brain Pill Product
Table 119. NOW Foods Recent Development
Table 120. Alternascript Company Information
Table 121. Alternascript Description and Business Overview
Table 122. Alternascript Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Alternascript Brain Pill Product
Table 124. Alternascript Recent Development
Table 125. Teva Pharmaceutical Industries Ltd. Company Information
Table 126. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 127. Teva Pharmaceutical Industries Ltd. Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Teva Pharmaceutical Industries Ltd. Brain Pill Product
Table 129. Teva Pharmaceutical Industries Ltd. Recent Development
Table 130. Peak Nootropics Company Information
Table 131. Peak Nootropics Description and Business Overview
Table 132. Peak Nootropics Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Peak Nootropics Brain Pill Product
Table 134. Peak Nootropics Recent Development
Table 135. KeyView Labs Company Information
Table 136. KeyView Labs Description and Business Overview
Table 137. KeyView Labs Brain Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. KeyView Labs Brain Pill Product
Table 139. KeyView Labs Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Brain Pill Distributors List
Table 143. Brain Pill Customers List
Table 144. Brain Pill Market Trends
Table 145. Brain Pill Market Drivers
Table 146. Brain Pill Market Challenges
Table 147. Brain Pill Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Brain Pill Product Picture
Figure 2. Global Brain Pill Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Brain Pill Sales Market Share by Type in 2024 & 2031
Figure 4. Fish Oil Product Picture
Figure 5. Resveratrol Product Picture
Figure 6. Creatine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Brain Pill Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Brain Pill Sales Market Share by Application in 2024 & 2031
Figure 10. Online Sales Examples
Figure 11. Offline Sales Examples
Figure 12. Global Brain Pill Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Brain Pill Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Brain Pill Sales (K Units) Growth Rate (2020-2031)
Figure 15. Global Brain Pill Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 16. Brain Pill Report Years Considered
Figure 17. Global Market Brain Pill Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Brain Pill Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Brain Pill Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Brain Pill Sales (K Units) Growth Rate (2020-2031)
Figure 21. Europe Brain Pill Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Brain Pill Sales (K Units) Growth Rate (2020-2031)
Figure 23. China Brain Pill Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Brain Pill Sales (K Units) Growth Rate (2020-2031)
Figure 25. Japan Brain Pill Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Brain Pill Sales (K Units) Growth Rate (2020-2031)
Figure 27. Global Brain Pill Revenue Share by Type (2020-2025)
Figure 28. Global Brain Pill Sales Share by Type (2026-2031)
Figure 29. Global Brain Pill Revenue Share by Type (2026-2031)
Figure 30. Global Brain Pill Revenue Share by Application (2020-2025)
Figure 31. Global Brain Pill Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Brain Pill Sales Share by Application (2026-2031)
Figure 33. Global Brain Pill Revenue Share by Application (2026-2031)
Figure 34. Global Brain Pill Sales Share by Company (2024)
Figure 35. Global Brain Pill Revenue Share by Company (2024)
Figure 36. Global 5 Largest Brain Pill Players Market Share by Revenue in Brain Pill: 2020 & 2024
Figure 37. Brain Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Brain Pill
Figure 39. Manufacturing Process Analysis of Brain Pill
Figure 40. Brain Pill Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
den_biaoTiZhungShi

Related Reports

Global Brain Pill Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-09-06

Pages: 97 Pages

Report ld: 4977447

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English

English

Offline

HITESH

English

English

Offline

TANG XIN

Japanese

Japanese

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

Offline

DAMON

Chinese

Chinese

Offline

General Email:

REPORT COVERAGE

zhankai
den_ic7

Market Segmentation

den_ic7

QYResearch's Strengths

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

Interest In This Report?

Get A Free Sample

Pre-Order Enquiry

OR

Need a Tailored Report?

Customize this report to your needs.

Customize This Report

den_gou

Fact Checked

den_gou

Cite this Research

biaoTi

WORLD WIDE OFFICE